Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab with Docetaxel and Radiation in Head and Neck Cancer
NCT00281840Phase 2Completed
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Sep 2005
- Primary completion
- Apr 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Case Comprehensive Cancer Center. Started Sep 2005; status: completed.
02
Drugs
bevacizumab
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00281840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00281840.